Cited by 4Thyroid Disorders and TreatmentsOphthalmology and Eye DisordersThyroid Cancer Diagnosis and Treatment

Images in Endocrine Pathology: Thyrotoxicosis Associated with Destructive Thyroiditis

Mete, Ozgur, Asa, Sylvia L.·2012·Endocrine Pathology

Integrity signals

Registry

Crossref · 10.1007/s12022-012-9209-8

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Type 1 AIT tends to occur in patients with underlying thyroid autonomy in a nodular goiter or GD, whereas type 2 AIT occurs as a result of direct damage or induction of apoptosis in thyrocytes by amiodarone.

    “Type 1 AIT tends to occur in patients with underlying thyroid autonomy in a nodular goiter, or GD, whereas type 2 AIT occurs as a result of direct damage or induction of apoptosis in thyrocytes by amiodarone (579-582).”
  • Two distinct mechanisms have been proposed in the development of AIT: an iodine-induced form of hyperthyroidism (type 1 AIT) due to the high iodine content of amiodarone (37% by molecular weight) and a destructive thyroiditis (type 2 AIT) due to direct toxicity of amiodarone on follicular cells.

    “Two distinct mechanisms have been proposed in the development of AIT, including an iodine-induced form of hyperthyroidism (type 1 AIT) due to the high iodine content of amiodarone (37% by molecular weight) and a destructive thyroiditis (type 2 AIT) due to direct toxicity of amiodarone on follicular cells.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mete, O., & Asa, S. L.
Affiliations
University Health Network (CA)
Venue
Endocrine Pathology
Published
2012-05-15
Volume
23
Issue
3
Pages
212-214
ISSN
  • 1046-3976 (ISSN-L)
  • 1559-0097
OpenAlex
W2026055815
Cited by
4
References
6
Citations by year
2022: 2 · 2016: 1 · 2013: 1
FWCI
0.26
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Pathology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Ophthalmology and Eye Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
thyrotoxicosis, destructive thyroiditis, Graves' disease, thyroid pathology
MeSH terms
Amiodarone, Heart Diseases, Humans, Male, Middle Aged, Thyroidectomy, Thyroiditis, Thyrotoxicosis, Thyrotropin, Thyroxine, Triiodothyronine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review